Analyst Profile

Followed by 39 followers
.
David Risinger

David Risinger

SVB Securities
Wall Street Analyst
#2,016 out of 8,160 Wall Street Analysts
#4,294 out of 24,427 experts

Success Rate

57%
135 out of 236 transactions made a profit

Average Return

+3.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying David Risinger's trades since 2012 and holding each position for 1 Year would result in 57.20% of your transactions generating a profit, with an average return of 3.7% per rating.

Stock Rating Distribution

552Ratings
46.38% Hold
44.57% Buy
9.06% Sell
Distribution of David Risinger's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Horizon Therapeutics
(HZNP)
Rating:Buy
Date:Apr 02, 2020 - Apr 02, 2021
Return:+184.10%
The most profitable rating made by David Risinger

David Risinger's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Oracle
Sep 21, 2012
Buy
Reiterated
$36.00
(-56.81% Downside)
3Ratings
100%
+3.50%
WCRX
Warner Chilcott
May 13, 2013
Hold
Upgraded
3Ratings
0%
-49.95%
~FRX
Forest Labs
Jun 18, 2014
Buy
Initiated
2Ratings
100%
+1.50%
DPLO
Diplomat Pharmacy
Oct 02, 2015
Hold
Downgraded
1Ratings
0.00%
AmerisourceBergen
Nov 16, 2015
Hold
Upgraded
2Ratings
0%
-2.80%
SGNT
Sagent Pharm
Jun 06, 2016
Hold
Assigned
1Ratings
0.00%
Assertio Therapeutics
Oct 31, 2018
Hold
Reiterated
$5.00
(63.40% Upside)
3Ratings
0.00%
AGN
Allergan
Jan 30, 2019
Hold
Downgraded
20Ratings
50%
+4.10%
MNKKQ
Mallinckrodt
Aug 09, 2019
Hold
Reiterated
$5.00
(24900.00% Upside)
17Ratings
0%
-34.29%
Amneal Pharmaceuticals
Apr 02, 2020
Hold
Reiterated
$3.00
(23.46% Upside)
4Ratings
0%
-19.20%
List of latest recommendations made by David Risinger. Click to expand and see David Risinger's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >